Advanced

Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010

Brinckmann, Sarah; da Costa, Kelly; van Gils, Marit J.; Hallengard, David; Klein, Katja; Madeira, Luisa; Mainetti, Lara; Palma, Paolo; Raue, Katharina and Reinhart, David, et al. (2011) In Journal of Translational Medicine 9.
Abstract
Novel, exciting intervention strategies to prevent infection with HIV have been tested in the past year, and the field is rapidly evolving. EUROPRISE is a network of excellence sponsored by the European Commission and concerned with a wide range of activities including integrated developmental research on HIV vaccines and microbicides from discovery to early clinical trials. A central and timely theme of the network is the development of the unique concept of co-usage of vaccines and microbicides. This review, prepared by the PhD students of the network captures much of the research ongoing between the partners. The network is in its 5(th) year and involves over 50 institutions from 13 European countries together with 3 industrial... (More)
Novel, exciting intervention strategies to prevent infection with HIV have been tested in the past year, and the field is rapidly evolving. EUROPRISE is a network of excellence sponsored by the European Commission and concerned with a wide range of activities including integrated developmental research on HIV vaccines and microbicides from discovery to early clinical trials. A central and timely theme of the network is the development of the unique concept of co-usage of vaccines and microbicides. This review, prepared by the PhD students of the network captures much of the research ongoing between the partners. The network is in its 5(th) year and involves over 50 institutions from 13 European countries together with 3 industrial partners; GSK, Novartis and Sanofi-Pasteur. EUROPRISE is involved in 31 separate world-wide trials of Vaccines and Microbicides including 6 in African countries (Tanzania, Mozambique, South Africa, Kenya, Malawi, Rwanda), and is directly supporting clinical trials including MABGEL, a gp140-hsp70 conjugate trial and HIVIS, vaccine trials in Europe and Africa. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Translational Medicine
volume
9
publisher
BioMed Central
external identifiers
  • wos:000290175100001
  • scopus:79953869416
ISSN
1479-5876
DOI
10.1186/1479-5876-9-40
language
English
LU publication?
yes
id
d445f8aa-dd3b-40b4-ae91-db2b09942d02 (old id 1987783)
date added to LUP
2011-07-01 09:26:51
date last changed
2017-01-01 05:35:48
@article{d445f8aa-dd3b-40b4-ae91-db2b09942d02,
  abstract     = {Novel, exciting intervention strategies to prevent infection with HIV have been tested in the past year, and the field is rapidly evolving. EUROPRISE is a network of excellence sponsored by the European Commission and concerned with a wide range of activities including integrated developmental research on HIV vaccines and microbicides from discovery to early clinical trials. A central and timely theme of the network is the development of the unique concept of co-usage of vaccines and microbicides. This review, prepared by the PhD students of the network captures much of the research ongoing between the partners. The network is in its 5(th) year and involves over 50 institutions from 13 European countries together with 3 industrial partners; GSK, Novartis and Sanofi-Pasteur. EUROPRISE is involved in 31 separate world-wide trials of Vaccines and Microbicides including 6 in African countries (Tanzania, Mozambique, South Africa, Kenya, Malawi, Rwanda), and is directly supporting clinical trials including MABGEL, a gp140-hsp70 conjugate trial and HIVIS, vaccine trials in Europe and Africa.},
  author       = {Brinckmann, Sarah and da Costa, Kelly and van Gils, Marit J. and Hallengard, David and Klein, Katja and Madeira, Luisa and Mainetti, Lara and Palma, Paolo and Raue, Katharina and Reinhart, David and Reudelsterz, Marc and Ruffin, Nicolas and Seifried, Janna and Schaefer, Katrein and Sheik-Khalil, Enas and Skold, Annette and Uchtenhagen, Hannes and Vabret, Nicolas and Ziglio, Serena and Scarlatti, Gabriella and Shattock, Robin and Wahren, Britta and Gotch, Frances},
  issn         = {1479-5876},
  language     = {eng},
  publisher    = {BioMed Central},
  series       = {Journal of Translational Medicine},
  title        = {Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010},
  url          = {http://dx.doi.org/10.1186/1479-5876-9-40},
  volume       = {9},
  year         = {2011},
}